Frontlight ResearchEarly access
Trial site
University of Utah Clinical Neurosciences Center
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy4 trials
- Epilepsy3 trials
- Myotonic dystrophy2 trials
- Stroke2 trials
- Heart failure1 trial
- Phase
- Phase 38 trials
- Phase 11 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Terminated3 trials
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Pfizer4 trials
- Xenon Pharmaceuticals Inc.3 trials
- Bayer2 trials
- AMO Pharma Limited1 trial
- Dyne Therapeutics1 trial
Running trials
Recruiting
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myotonic dystrophy2 recruiting
- Epilepsy1 recruiting
Closed trials
Terminated
Completed
Terminated
Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy
Completed
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026